• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prime Medicine Inc (NQ: PRME )

4.030 +0.150 (+3.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 528,288
Open 3.900
Bid (Size) 4.030 (2)
Ask (Size) 4.120 (9)
Prev. Close 3.880
Today's Range 3.850 - 4.050
52wk Range 3.280 - 9.860
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 High-Growth Stocks That Could Deliver Parabolic Returns
October 28, 2024
These 12 innovative companies could deliver exponential returns over the next quarter century. 
Via The Motley Fool
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress
October 24, 2024
From Prime Medicine, Inc.
Via GlobeNewswire

Performance

YTD
-54.00%
-54.00%
1 Month
+18.18%
+18.18%
3 Month
-10.44%
-10.44%
6 Month
-25.37%
-25.37%
1 Year
-48.33%
-48.33%

More News

Read More
Why I Keep Buying These 14 Incredible Growth Stocks
October 16, 2024
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
October 15, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
September 30, 2024
Via The Motley Fool
Dow Dips 300 Points; Emcore Shares Spike Higher
September 30, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
September 30, 2024
Via Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
September 30, 2024
Via Benzinga
Exposures Fossil Fuels
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
September 30, 2024
Via Benzinga
Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline
September 30, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via Benzinga
Prime Medicine Unveils Strategically Focused Pipeline
September 30, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
September 30, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
2 Growth Stocks That Could Make You Richer
August 28, 2024
Via The Motley Fool
Prime Medicine to Participate in Upcoming Investor Conferences
August 28, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024
August 08, 2024
Via InvestorPlace
Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at Upcoming Investor Conferences
May 30, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Via InvestorPlace
Exposures Product Safety
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
May 25, 2024
Via The Motley Fool
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
May 17, 2024
Via InvestorPlace
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
Via InvestorPlace
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
May 10, 2024
Via InvestorPlace
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024
From Prime Medicine, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap